Ike Swetlitz

Health journalist at Bloomberg News based in Boston, covering the business of health and medicine with a current focus on health insurance, pharmacies, and neurotechnology. He previously reported for Searchlight New Mexico and STAT, where his coverage included artificial intelligence, medical science, pharmaceuticals, and genetic engineering.

China’s Brain-Chip Startups Race Toward Commercial Medical Use

Bloomberg Primer reports on the race to commercialize brain-computer interfaces through NeuroXess, a Shanghai startup testing an implanted device in a paralyzed patient. The source presents BCI less as near-term human enhancement than as an assistive medical technology still facing safety, regulatory and reimbursement tests, while arguing that China’s policy support could help its companies compete with better-funded US rivals.

Bloomberg OriginalsJun 8, 20267 min read